Matteo Fassan

Matteo Fassan's AcademicInfluence.com Rankings

Matteo Fassan

Physics

#6758

World Rank

#8742

Historical Rank

physics Degrees

Download Badge

Physics

Matteo Fassan's Degrees

PhD Physics University of Milan
Masters Physics University of Milan

Why Is Matteo Fassan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Matteo Fassan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers (2018) (981)
Micro-RNA profiling in kidney and bladder cancers. (2007) (629)
Whole-genome landscape of pancreatic neuroendocrine tumours (2017) (616)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas (2013) (555)
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets (2009) (490)
Patterns of somatic structural variation in human cancer genomes (2020) (377)
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial (2017) (347)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas (2014) (276)
MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer (2014) (273)
Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study (2010) (253)
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples (2013) (228)
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. (2018) (216)
Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial (2016) (193)
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4 (2018) (191)
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ (2018) (181)
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation (2014) (178)
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups (2014) (161)
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin‐remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D (2016) (160)
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial. (2018) (159)
Gastric Cancer as Preventable Disease (2017) (153)
An antimetastatic role for decorin in breast cancer. (2008) (145)
Autoimmune gastritis: Pathologist's viewpoint. (2015) (138)
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers (2014) (137)
Gastritis: the histology report. (2011) (136)
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer (2015) (133)
Epithelial–mesenchymal transition in malignant mesothelioma (2012) (133)
MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. (2012) (121)
MicroRNA expression profiling in human Barrett's carcinogenesis (2011) (118)
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients (2018) (116)
MicroRNA expression profiling of male breast cancer (2009) (115)
Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. (2011) (111)
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5. (2016) (107)
Mixed Adenoneuroendocrine Carcinomas of the Gastrointestinal Tract: Targeted Next-Generation Sequencing Suggests a Monoclonal Origin of the Two Components (2014) (105)
Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel (2013) (105)
Reprogramming normal cells into tumor precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties (2020) (101)
Autoimmune gastritis: histology phenotype and OLGA staging (2012) (100)
The Hyaluronic Acid Receptor CD44 Coordinates Normal and Metaplastic Gastric Epithelial Progenitor Cell Proliferation* (2013) (94)
Tumor mutation burden: from comprehensive mutational screening to the clinic (2019) (92)
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis. (2016) (89)
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. (2016) (88)
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma (2017) (88)
miR-15b/16-2 deletion promotes B-cell malignancies (2015) (84)
Epidemiology of Gastric Cancer (2015) (82)
Diffuse Leptomeningeal Glioneuronal Tumors: A New Entity? (2010) (79)
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice. (2016) (79)
Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options (2014) (78)
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long‐term Follow‐up Study of 7436 Patients (2018) (76)
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies (2015) (76)
Squamous cell carcinoma antigen in human liver carcinogenesis (2007) (75)
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients (2016) (74)
Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis. (2016) (73)
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis (2011) (73)
The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies (2012) (72)
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers (2015) (71)
Role and accuracy of rapid on‐site evaluation of CT‐guided fine needle aspiration cytology of lung nodules (2011) (71)
B-cell malignancies in microRNA Eμ-miR-17∼92 transgenic mice (2013) (71)
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes. (2018) (70)
Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. (2009) (70)
Immunotherapy in Gastrointestinal Cancers (2017) (69)
Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis. (2017) (68)
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. (2020) (67)
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers (2016) (67)
Pathology - grading and staging of GEP-NETs. (2012) (67)
Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian Patients (2008) (66)
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 (2015) (66)
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. (2019) (66)
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. (2015) (65)
Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells (2014) (64)
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives (2019) (64)
miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer (2020) (64)
Early HER2 dysregulation in gastric and oesophageal carcinogenesis (2012) (63)
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma (2016) (62)
Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. (2011) (62)
A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment. (2016) (62)
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. (2011) (61)
PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis (2012) (59)
Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer (2016) (58)
Consistency and reproducibility of next‐generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens (2017) (58)
Different prognostic roles of tumor suppressor gene BAP1 in cancer: A systematic review with meta‐analysis (2016) (58)
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas (2014) (57)
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study (2017) (57)
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma (2015) (56)
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. (2013) (55)
Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma (2018) (55)
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression (2014) (54)
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer (2012) (53)
Cytokine BAFF Released by Helicobacter pylori–Infected Macrophages Triggers the Th17 Response in Human Chronic Gastritis (2014) (53)
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers (2013) (52)
Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma (2014) (51)
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma (2020) (51)
microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6 (2012) (51)
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research (2018) (49)
Exome sequencing identifies frequent inactivating mutations in BAP 1 , ARID 1 A and PBRM 1 in intrahepatic cholangiocarcinomas (2014) (49)
Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. (2012) (48)
MITOSTATIN, a Putative Tumor Suppressor on Chromosome 12q24.1, is Down-regulated in Human Bladder and Breast Cancer (2008) (48)
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization (2019) (48)
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies☆ (2021) (47)
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response (2011) (47)
PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways (2017) (46)
Next-generation histopathologic diagnosis: a lesson from a hepatic carcinosarcoma. (2014) (46)
Long-Term Follow-up of Barrett’s Epithelium: Medical Versus Antireflux Surgical Therapy (2011) (46)
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract (2014) (46)
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread (2009) (45)
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. (2013) (45)
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study. (2019) (44)
Programmed cell death 4 protein in esophageal cancer. (2010) (44)
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis (2014) (44)
Evolution of HER2-low expression from primary to recurrent breast cancer (2021) (44)
Proepithelin is an autocrine growth factor for bladder cancer. (2009) (43)
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer (2020) (43)
HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases. (2015) (43)
Characterisation of the immune-related transcriptome in resected biliary tract cancers (2017) (42)
Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal. (2016) (42)
LONG-NONCODING RNAs in gastroesophageal cancers (2018) (42)
Sex differences in oncogenic mutational processes (2019) (41)
Young investigator challenge: MicroRNA‐21/MicroRNA‐126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology (2016) (41)
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis (2010) (40)
Advanced precancerous lesions within the GI tract: the molecular background. (2013) (40)
Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice. (2014) (40)
PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target (2019) (39)
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis (2016) (39)
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial (2016) (39)
Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis (2014) (39)
Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. (2011) (38)
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. (2012) (38)
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies (2015) (38)
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells. (2015) (38)
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer (2015) (38)
Profiling of expression of human papillomavirus-related cancer miRNAs in penile squamous cell carcinomas. (2014) (37)
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes (2018) (37)
Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review (2012) (37)
The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. (2013) (37)
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer (2021) (37)
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia (2013) (37)
The molecular landscape of colitis-associated carcinogenesis. (2017) (36)
PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications. (2018) (36)
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study (2020) (36)
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine (2018) (36)
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis (2014) (36)
Patient-Derived Scaffolds of Colorectal Cancer Metastases as an Organotypic 3D Model of the Liver Metastatic Microenvironment (2020) (35)
Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes (2019) (35)
Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia (2011) (35)
KRAS induces lung tumorigenesis through microRNAs modulation (2018) (35)
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases (2021) (34)
Selective targeting of point-mutated KRAS through artificial microRNAs (2017) (34)
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations (2018) (34)
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma (2018) (34)
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases (2019) (34)
Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer (2016) (34)
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma (2017) (34)
Helicobacter pylori Affects the Antigen Presentation Activity of Macrophages Modulating the Expression of the Immune Receptor CD300E through miR-4270 (2017) (33)
Aurora kinase A in Barrett's carcinogenesis. (2010) (33)
miRNAs in precancerous lesions of the gastrointestinal tract. (2011) (33)
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer (2020) (32)
A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial (2018) (31)
Survivin expression impacts prognostically on NSCLC but not SCLC. (2013) (31)
Knockout of both miR-15/16 loci induces acute myeloid leukemia (2018) (31)
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer. (2016) (31)
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma (2017) (30)
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes (2015) (30)
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis (2016) (29)
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (29)
Anterior Gradient 2 Overexpression in Lung Adenocarcinoma (2012) (29)
Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens (2019) (29)
Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides (2021) (28)
The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization (2021) (28)
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis (2019) (28)
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 (2014) (28)
Modulation of Biliary Cancer Chemo‐Resistance Through MicroRNA‐Mediated Rewiring of the Expansion of CD133+ Cells (2019) (28)
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab. (2019) (28)
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. (2012) (28)
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis (2017) (28)
Molecular Diagnostics in Pathology: Time for a Next-Generation Pathologist? (2018) (27)
Primary Squamous Cell Carcinoma of the Thyroid: Immunohistochemical Profile and Literature Review (2007) (27)
Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers (2017) (27)
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas (2018) (27)
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis (2018) (26)
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. (2021) (26)
Fine needle aspiration of non‐small cell lung cancer: current state and future perspective (2012) (26)
A 4‐MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears (2014) (26)
Neck emergency due to parathyroid adenoma bleeding: a case report (2009) (26)
Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells (2011) (25)
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis (2015) (25)
Recellularized Colorectal Cancer Patient-Derived Scaffolds as In Vitro Pre-Clinical 3D Model for Drug Screening (2020) (25)
Clinical guidelines: Secondary prevention of gastric cancer (2012) (25)
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial (2019) (25)
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population. (2020) (25)
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma (2017) (25)
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma (2016) (25)
Loss of miR-204 expression is a key event in melanoma (2018) (24)
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages. (2020) (24)
Current role of non-coding RNAs in the clinical setting (2019) (23)
Low‐grade neuroepithelial tumor: Unusual presentation in an adult without history of seizures (2018) (23)
YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS–STING (2022) (23)
Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. (2012) (23)
First-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS-BRAF wild-type metastatic colorectal cancer elderly patients: The PANDA study. (2020) (23)
MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis (2014) (23)
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia. (2018) (23)
PD‐L1 overexpression in ampulla of Vater carcinoma and its pre‐invasive lesions (2017) (22)
Tryptophan metabolism along the kynurenine and serotonin pathways reveals substantial differences in colon and rectal cancer (2017) (22)
Early miR-223 Upregulation in Gastroesophageal Carcinogenesis (2017) (22)
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker. (2017) (22)
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence (2021) (22)
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer (2013) (22)
Exosomal miRNA signatures of pancreatic lesions (2020) (22)
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer (2017) (21)
CDX2 hox gene product in a rat model of esophageal cancer (2009) (21)
In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma. (2015) (21)
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens (2021) (21)
Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes (2020) (20)
Liver Steatosis in Children With Chronic Hepatitis C (2006) (20)
Secondary Prevention of Epidemic Gastric Cancer in the Model of Helicobacter pylori-Associated Gastritis (2014) (20)
Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. (2008) (20)
The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury (2021) (20)
PD-L1 expression in gastroesophageal dysplastic lesions (2019) (20)
PDCD4 expression in thyroid neoplasia (2012) (19)
PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus (2019) (19)
Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells (2019) (19)
A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib. (2016) (19)
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers (2020) (19)
MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis. (2015) (19)
A KRAS-responsive long non-coding RNA controls microRNA processing (2021) (19)
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice (2020) (18)
Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study (2014) (18)
Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer (2020) (18)
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer (2019) (18)
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis (2016) (18)
Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs) (2018) (18)
Plexiform fibromyxoma of the gallbladder. (2015) (17)
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status (2019) (17)
Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. (2010) (17)
Detection of MicroRNAs in Archival Cytology Urine Smears (2013) (17)
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA (2020) (17)
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer (2019) (17)
A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer (2018) (17)
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden. (2020) (17)
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study (2021) (17)
Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected death. (2018) (17)
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome (2016) (17)
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe (2020) (17)
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome (2021) (17)
Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up. (2012) (16)
Concomitant IDH wild‐type glioblastoma and IDH1‐mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome (2018) (16)
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting (2021) (16)
NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis (2021) (16)
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment (2022) (16)
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials (2018) (16)
From Barrett metaplasia to esophageal adenocarcinoma: the molecular background. (2016) (16)
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis (2020) (15)
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations (2017) (15)
Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus (2017) (15)
Cholangiocarcinoma (2021) (15)
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study (2020) (15)
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas (2021) (15)
The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis (2020) (15)
Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett’s esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population (2016) (15)
Microsatellite instability and hMLH1 and hMSH2 expression in renal tumors. (2010) (14)
Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin’s Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study (2015) (14)
MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions. (2018) (14)
Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma. (2010) (14)
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies (2020) (14)
Fine‐needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocytosis (2011) (14)
Peptic Ulcer Disease and Helicobacter pylori Infection in Different Siberian Ethnicities (2017) (14)
Neuroendocrine neoplasms of the esophagus and stomach (2021) (13)
Re: Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. (2012) (13)
MicroRNAs and targeted therapy: small molecules of unlimited potentials. (2013) (13)
Clear cell colorectal carcinoma: Time to clarify diagnosis. (2017) (13)
Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs (2019) (13)
Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model (2018) (13)
Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers. (2019) (13)
RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients (2018) (13)
The impact of recent next generation sequencing and the need for a new classification in gastric cancer. (2021) (13)
Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'. (2014) (13)
Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain. (2011) (13)
Micronuclei and broken eggs in human liver carcinogenesis. (2008) (13)
Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity (2019) (12)
Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients (2022) (12)
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis. (2020) (12)
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients. (2021) (12)
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes (2016) (12)
Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study (2017) (12)
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial. (2020) (12)
Expression of DRD 2 is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice Short Title : DRD 2 and pancreatic ductal adenocarcinoma (2016) (12)
Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma (2018) (12)
Helicobacter pylori heteroresistance to clarithromycin in adults—New data by in situ detection and improved concept (2019) (12)
Gastritis: update on etiological features and histological practical approach (2020) (12)
Prevention Strategies for Esophageal Cancer—An Expert Review (2021) (11)
Targeted therapies in the management of metastatic bladder cancer (2007) (11)
Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. (2012) (11)
SARS-CoV-2 and hepatitis. (2020) (11)
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies (2022) (11)
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer (2022) (11)
Human papillomavirus infection is not involved in esophageal verrucous carcinoma. (2019) (11)
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 (2017) (11)
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy (2016) (11)
A 14‐YEAR‐OLD GIRL WITH MULTIPLE TUMORS (2012) (11)
Non-coding RNAs, a real Next-Gen Class of Biomarkers? (2019) (11)
Sequential development of hepatocellular carcinoma and liver angiosarcoma in a vinyl chloride-exposed worker. (2016) (11)
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis12 (2018) (11)
Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study (2020) (11)
Team work and cytopathology molecular diagnosis of solid pancreatic lesions (2017) (11)
Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma. (2018) (10)
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling (2021) (10)
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study (2019) (10)
Very Early Onset-IBD: evidence for the need of a multidisciplinary approach (2021) (10)
Gastritis staging as a clinical priority (2018) (10)
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study (2021) (10)
Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions (2018) (10)
An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities (2020) (10)
Molecular genetics of prostate cancer: clinical translational opportunities. (2007) (10)
Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia. (2009) (10)
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation (2020) (10)
Mesenchymal tumours of the gastrointestinal tract (2021) (10)
Treatment personalization in gastrointestinal neuroendocrine tumors (2021) (9)
CD80 expression promotes immune surveillance in Barrett’s metaplasia (2019) (9)
MicroRNA Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options (2012) (9)
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies (2022) (9)
BRAF p.V600E‐specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling (2017) (9)
18F-FDG PET Findings and GLUT-1 Expression in IPMNs of the Pancreas (2008) (9)
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa (2017) (9)
Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report. (2019) (9)
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials. (2020) (9)
Duodenal Histological Findings and Risk of Coeliac Disease in Subjects with Autoimmune Atrophic Gastritis: A Retrospective Evaluation (2020) (9)
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy (2017) (9)
Significance of the prognostic stratification of extranodal extension in colorectal cancer. (2016) (9)
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab (2020) (8)
Malignant epithelial/exocrine tumors of the pancreas (2020) (8)
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (2018) (8)
Realdo Colombo's "De Re Anatomica": the renaissance origin of the term "placenta" and its historical background. (2012) (8)
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis (2021) (8)
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy (2020) (8)
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155). (2019) (8)
Early signet ring cell carcinoma arising from colonic adenoma: the molecular profiling supports the adenoma-carcinoma sequence. (2016) (8)
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. (2021) (8)
Non gastro-esophageal reflux disease related esophagitis: an overview with a histologic diagnostic approach (2020) (8)
Role of NS1 and TLR3 in Pathogenesis and Immunity of WNV (2019) (8)
AMPKα loss promotes KRAS-mediated lung tumorigenesis (2021) (8)
Letter: gastric cancer and pernicious anaemia – often Helicobacter pylori in disguise (2013) (7)
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition (2020) (7)
Anaplastic Astrocytoma: State of the art and future directions. (2020) (7)
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer (2021) (7)
Gastro-esophageal reflux disease and Barrett’s esophagus: an overview with an histologic diagnostic approach (2020) (7)
Liquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study. (2018) (7)
CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation (2021) (7)
Malignant Perivascular Epithelioid Cell Tumor of the Esophagus (2012) (7)
Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis. (2017) (7)
Neuroendocrine neoplasms of the duodenum, ampullary region, jejunum and ileum (2021) (7)
Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency. (2020) (7)
Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus. (2016) (7)
Genomic characterization of hepatoid tumors: context matters. (2021) (7)
Next-Generation Sequencing in Tumor Diagnosis and Treatment (2020) (7)
The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma (2021) (7)
Clinical practice and ideal liver biopsy sampling standards:Not just a matter of centimeters (2006) (7)
miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma (2021) (7)
Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms (2017) (7)
Concurrent pheochromocytoma and cortical carcinoma of the adrenal gland (2011) (6)
Pancreatic endocrine tumor in multiple endocrine neoplasia type 1 syndrome with intraductal growth into the main pancreatic duct. (2009) (6)
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer (2019) (6)
Extraskeletal Myxoid Chondrosarcoma of the Foot Clinically Mimicking Plantar Fibromatosis. (2017) (6)
Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network (2021) (6)
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study. (2022) (6)
Congenital Pulmonary Airway Malformation (CPAM) [Congenital Cystic Adenomatoid Malformation] Associated with Tracheoesophageal Fistula and Agensesis of the Corpus Callosum (2012) (6)
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. (2021) (6)
MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives (2021) (6)
Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status. (2019) (6)
Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance (2017) (6)
The evolving landscape of Anatomic Pathology. (2022) (6)
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours (2017) (6)
Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions (2021) (6)
Inflammatory myofibroblastic tumor as adverse outcome of eosinophilic esophagitis. (2009) (6)
Synchronous nodal metastatic risk in screening detected and endoscopically removed pT1 colorectal cancers. (2020) (6)
Serotonin-Secreting Neuroendocrine Tumours of the Pancreas (2020) (6)
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival. (2021) (6)
Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study (2017) (6)
Heterogeneous Her2/Neu expression in gastric and gastroesophageal cancer. (2016) (6)
The Risk of Malignancies in Celiac Disease—A Literature Review (2021) (6)
Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components. (2017) (6)
The Role of Helicobacter pylori in the Spectrum of Barrett's Carcinogenesis (2009) (5)
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis (2019) (5)
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection (2022) (5)
“Stranger things” in the gut: uncommon items in gastrointestinal specimens (2021) (5)
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group (2022) (5)
Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model. (2015) (5)
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer (2020) (5)
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage (2021) (5)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. (2014) (5)
MGMT promoter methylation in pediatric high-grade gliomas (2010) (5)
Radiological-Pathological Comparison in a Case of Conjoined Gnatho-Thoracopagus Twins (2009) (5)
Abstract 235: Preclinical activity of an antibody drug conjugate targeting tumor specificmuc1 structural peptide-glycotope (2019) (4)
The original sin of oesophageal mucosa. (2011) (4)
HER-2/neu expression is consistent in primary and metastatic lung adenocarcinoma. (2011) (4)
Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study (2022) (4)
Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients (2020) (4)
MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. (2012) (4)
UEG Week 2016 Poster Presentations (2016) (4)
BRAF-mutated colorectal adenocarcinomas: pathological heterogeneity and clinical implications. (2022) (4)
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice (2022) (4)
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma (2021) (4)
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy (2022) (4)
Therapy for Non-Muscle Invasive Bladder Cancer: HP-NAP (2012) (4)
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study (2021) (4)
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience (2021) (4)
Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across Europe (2020) (4)
Histopathology of intestinal villi in neonatal and paediatric age: main features with clinical correlation - Part II (2021) (4)
Simple mucinous cyst: another potential cancer precursor in the pancreas? Case report with molecular characterization and systematic review of the literature (2021) (4)
There is much more to rely on histology than the sole endoscopy tells us (2019) (4)
FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint (2022) (4)
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling (2022) (4)
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases (2022) (4)
Clinico-pathological and molecular characterization of BRAF mutant metastatic colorectal cancer (mCRC): Are all mutations created equal? (2018) (4)
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model (2020) (4)
New genomic landscapes and therapeutic targets for biliary tract cancers. (2016) (4)
MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors (2021) (4)
Ramucirumab: the long and winding road toward being an option for mCRC treatment (2019) (4)
Fhit down-regulation is an early event in pancreatic carcinogenesis (2017) (4)
CROCC-mutated rhabdoid colorectal carcinoma showing in intercellular spaces lamellipodia and cellular projections revealed by electron microscopy (2019) (4)
Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction (2020) (3)
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer? (2018) (3)
The war of the worlds: metaplastic versus nonmetaplastic atrophic gastritis. (2011) (3)
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment (2021) (3)
mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs. (2021) (3)
Seeding of tumour cells after fine needle aspiration cytology in liver nodules: myth or reality? (2010) (3)
Pathologist’s approach to paediatric and neonatal eosinophilic gastrointestinal disorders (2022) (3)
Establishment of a human 3D pancreatic adenocarcinoma model based on a patient-derived extracellular matrix scaffold. (2022) (3)
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases (2019) (3)
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (2018) (3)
Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis (2020) (3)
Histopathological landscape of rare oesophageal neoplasms (2020) (3)
4MO_PR HER2-low breast cancer: Evolution from primary breast cancer to relapse (2021) (3)
Histopathology of intestinal villi in neonatal and paediatric age: main features with clinical correlation - Part I (2021) (3)
DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases (2021) (3)
Microfluidic chip technology applied to fine‐needle aspiration cytology samples for IGH clonality assessment (2019) (3)
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases (2022) (3)
Clinical prognostic score of BRAF V600E mutated (BM) metastatic colorectal cancer (mCRC): Results from the “BRAF, BeCool” platform. (2018) (3)
Histology of the spleen in immune thrombocytopenia: clinical‐pathological characterization and prognostic implications (2020) (3)
Inflammatory and tumor-like lesions of the pancreas (2020) (3)
Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription (2022) (3)
Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study (2015) (3)
Esophageal squamous cell carcinoma metachronous to head and neck cancers. (2021) (3)
Abstract 258: MicroRNAs as biomarkers of resistance to HER2 inhibition in combination with chemotherapy in gastro-esophageal cancer (2020) (3)
Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature Review (2018) (3)
Insulin/IGF-1 Signaling Is Downregulated in Barrett’s Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial (2021) (3)
Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases (2021) (3)
Somatostatin Receptor Type 2 (SSTR2) in Bronchopulmonary Carcinoids (2010) (3)
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications. (2021) (3)
“Double Trouble” or an Amplification of the Triploidy Phenotype? (2013) (3)
Pattern-based Histologic Approach in Very Early Onset IBD: Main Features and Differential Diagnosis (2021) (3)
405MO Personalized circulating tumour DNA assay for the detection of minimal residual disease in CRC patients after resection of metastases (2020) (3)
Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease (2019) (3)
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study (2022) (3)
Pembrolizumab (Pem) in recurrent high-grade glioma (HGG) patients (PTS) with mismatch repair deficiency (MMRd): An observational study. (2019) (3)
Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC (2021) (3)
Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver. (2017) (3)
Publisher Correction: Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties (2020) (2)
From Open-Type Atrophic Gastritis to Gastritis Staging (2011) (2)
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas. (2022) (2)
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (2019) (2)
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer (2021) (2)
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma. (2022) (2)
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma (2019) (2)
Benign biliary neoplasms and biliary tumor precursors (2021) (2)
Epstein-Barr virus associated gastric dysplasia: a new rare entity? (2021) (2)
Onycholemmal carcinoma: A case report with its molecular profiling (2018) (2)
Pathologist's Role in the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) (2013) (2)
Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected death. (2018) (2)
Triumphs and tribulations of COVID-19 vaccines: Lessons to be learned from smallpox epidemics in the 1700s (2021) (2)
PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application (2022) (2)
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance. (2018) (2)
Erratum: Genetic features of metachronous esophageal cancer developed in hodgkin's lymphoma or breast cancer long-term survivors: An exploratory study (PLoS ONE (2015) 10:1 (e0117070) DOI: 10.1371/journal.pone.0117070) (2015) (2)
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (2)
Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response (2020) (2)
The histomorphological and molecular landscape of colorectal adenomas and serrated lesions (2021) (2)
P.123 MICRORNAS ARE DEREGULATED IN BARRETT'S CARCINOGENESIS (2010) (2)
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants (2022) (2)
Persistent Herpes Simplex Virus Type 1 Infection of Enteric Neurons Triggers CD8+ T Cell Response and Gastrointestinal Neuromuscular Dysfunction (2021) (2)
Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas (2021) (2)
Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter (2022) (2)
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? (2022) (2)
228 Predictive molecular biomarkers of renal clear cell carcinoma (2016) (2)
187 MicroRNA Expression Profiling of Human Barrett's Carcinogenesis (2010) (2)
Allelic Imbalance Analysis in Liquid Biopsy to Monitor Locally Advanced Esophageal Cancer Patients During Treatment (2020) (2)
Adenosquamous carcinoma of the papilla of Vater: A phenotypic heterogeneity characterized by a common molecular landscape (2018) (2)
212P HER2-low breast cancer: Evolution from primary tumor to residual disease after neoadjuvant treatment (2021) (2)
Abstract 3050: MicroRNA expression profiling of human Barrett's carcinogenesis (2010) (2)
ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality. (2021) (2)
Poorly Cohesive Carcinoma of the Nonampullary Small Intestine (2021) (2)
TRANSLATIONAL — BILIARY MIR 21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma (2018) (1)
Clear cell dysplasia in a sessile serrated adenoma. (2018) (1)
L22Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs) (2015) (1)
Circulating miR-652-3p as a biomarker of drug resistance in metastatic colorectal cancer patients (2019) (1)
Abstract LB-305: Circulating miR-652-3p as a biomarker of resistance to regorafenib in metastatic colorectal cancer patients (2019) (1)
Pembrolizumab (Pem) in recurrent high-grade glioma (HGG) patients with mismatch repair deficiency (MMRd): An observational study (2019) (1)
MicroRNA expression profiling of human metastatic cancers (2008) (1)
MicroRNA analysis as a potential diagnostic tool in the cytological diagnosis of non-small cell lung cancer. (2011) (1)
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study (2022) (1)
Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis (2019) (1)
PD-5 IDH1 in intrahepatic cholangiocarcinoma: A comparative genomic analysis and clinical impact (2022) (1)
Gastritis Stages in Monozygotic and Dizygotic Dyspeptic Twins (2020) (1)
Biomarker characterization in endometrial cancer in Italy: first survey data analysis (2022) (1)
Bone metastases from neuroendocrine tumors: clinical and biological considerations (2022) (1)
Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy (2016) (1)
Correction for Gasparini et al., Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation (2017) (1)
Letter: gastric atrophy as a precursor of gastric cancer – authors’ reply (2012) (1)
SP299MICRORNA-200B AS PREDICTIVE BIOMARKER OF CHRONIC KIDNEY DISEASE (CKD) IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY (2015) (1)
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ (2018) (1)
Abstract CT263: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: The PEGASUS trial (2020) (1)
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer (2019) (1)
Colorectal adenosquamous carcinoma: Peculiar morphologic features and distinct immunoprofiles in squamous and glandular components. (2022) (1)
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection (2022) (1)
Pancreatic Neuroendocrine Neoplasms and Gastrointestinal Stromal Tumors (2020) (1)
OC.10.1 TARGETED CONFOCAL ENDOMICROSCOPY FOR IN VIVO MOLECULAR IMAGING OF HER2 IN A RAT MODEL OF BARRETT'S ESOPHAGUS CARCINOGENESIS (2013) (1)
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features (2021) (1)
Correction: Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin’s Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study (2015) (1)
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis (2020) (1)
Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
Diffuse Leptomeningeal Glioneuronal Tumors: Histology. Is It a New Entity? (2012) (1)
Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches (2022) (1)
miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus. (2021) (1)
Mismatch repair status and gastro‐oesophageal dysplasia: need for a dedicated gastrointestinal pathologist? (2022) (1)
Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (1)
Objective Evidence of Gastro-Esophageal Reflux Disease is Rare in Patients with Autoimmune Gastritis. (2021) (1)
Pancreatic mucinous cystic tumor in Turner syndrome: How a tumor bends to a genetic disease☆ (2013) (1)
HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur (2012) (1)
Intra-Articular Tumors. (2021) (1)
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study. (2023) (1)
MA07.01 Dynamic Liquid Biopsy During Immunotherapy Anticipates Hyperprogression And Early Death in Advanced Non-Small Cell Lung Cancer (2021) (1)
Abstract 4977: MIR1307 mediates pancreatic cancer resistance to FOLFIRINOX chemotherapy by affecting response to DNA damage (2018) (1)
Effects of clusterin knock down on prostate cancer progression in the TRAMP model (2009) (1)
Abstract A113: The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome (2016) (1)
PO-472 MicroRNA as biomarkers of resistance to regorafenib in metastatic colorectal cancer patient (2018) (1)
HER2 overexpression is a suitable marker for “in vivo” targeted confocal endoscopy in a rat model of Barrett's Esophagus carcinogenesis (2012) (1)
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters. (2022) (1)
PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways (2017) (1)
Prospective analysis of microRNA 31-3p (miR31-3p) as a predictive biomarker of response to anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies (mABs) in patients with metastatic colorectal cancer (mCRC). (2019) (1)
HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma (2022) (1)
Journal of the Italian Society of Anatomic Pathology and Diagnostic Cytopathology, Italian Division of the International Academy of Pathology (2012) (0)
OC.03.2 CLAUDIN 18 EXPRESSION IN SMALL BOWEL ADENOCARCINOMA IS ASSOCIATED WITH NON-COELIAC ETIOLOGY AND GASTRIC FOVEOLAR DIFFERENTIATION (2022) (0)
Tumour-associated macrophages as major source of APRIL in gastric MALT lymphoma (2011) (0)
CMAR_A_194344 7845..7855 (2019) (0)
PUB038 Prognostic Impact of FOXP3-Positive Tumor Infiltrating Lymphocytes in Small-Cell Lung Cancers (2017) (0)
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series. (2022) (0)
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma (2022) (0)
PL2.2 Pembrolizumab (PEM) in recurrent high-grade glioma (HGG)patients with mismatch repair deficiency (dMMR): an observational study (2019) (0)
Identification of a nanostring signature that differentiates early pancreatic cancers according to stromal composition and predicts clinical outcome. (2019) (0)
Cholangiocarcinoma heterogeneity revealed by clinicopathological characteristics and multigene mutational profiling (2016) (0)
IPA-3 (PAK1 inhibitor) or OTSSP167 (MELK inhibitor) plus auranofin (PKCÎ¹ inhibitor), a therapeutic option for EGFR mutant, KRAS mutant and squamous cell non-small cell lung cancer (NSCLC). (2018) (0)
Jeremy Jass Prize for Research Excellence in Pathology 2014 (2016) (0)
The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis (2022) (0)
Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer (2022) (0)
Next-generation sequencing (NGS) for identifying actionable molecular alterations in patients with newly diagnosed and recurrent IDHwt-glioblastoma (GBM): A large mono-institutional experience. (2022) (0)
Electronic word count : 6370 words Number of figures and tables : 4 figures and 2 tables Abbreviations (2018) (0)
Mismatch repair deficiency (MMRd) in glioma patients (PTS): Frequency and correlation with clinical, histological and molecular characteristics. (2018) (0)
1311PNEXT GENERATION SEQUENCING (NGS) REVEALS QUALITATIVE AND QUANTITATIVE MOLECULAR HETEROGENEITY WITHIN EGFR-MUTANT ADVANCED LUNG ADENOCARCINOMA (ALA) PATIENTS (PTS) RECEIVING GEFITINIB (G). (2014) (0)
Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (2022) (0)
IMMUNOlogical microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT 2; NCT04917263): preliminary results on prediction of complete response to neoadjuvant therapy in rectal cancer (2022) (0)
The Thin Red Line between Pathological and Physiological Inflammatory Background in the Gastric Mucosa (2021) (0)
PC.01.6 EVOLUTION OF THE RESIDENT MICROBIOTA IN GASTRIC CARCINOGENESIS (2022) (0)
Prognostic significance of pathological sub-classification of pT3 rectal cancer (2021) (0)
Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma. (2023) (0)
Abstract 2373: Expression of exosomal let-7g in biofluids and outcome in colon cancer patient treated with anti-EGFR therapy (2021) (0)
Metastatic colorectal cancer (mCRC) patient derived organoids (PDOs) as a preclinical tool to understand mechanisms of resistance to anti-angiogenic drugs (2017) (0)
Sa1339 INTEROBSERVER CONSISTENCY ON THE HISTOLOGICAL ASSESSMENT OF SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA (2020) (0)
MITOSTATIN, A NOVEL MITOCHONDRIAL PROTEIN, THAT ACTS AS A TUMOR SUPPRESSOR IN PROSTATE CANCER CELLS (2008) (0)
Prognostic impact of extra-nodal extension on colon and rectal cancer should be investigated separately (2016) (0)
221 – Esophageal Adenocarcinoma Microenvironment: Cd34 Expression in Peritumoral Adipose Tissue is Associated with Tumor Necrosis and Impaired Immune Response Within the Tumor, and is Decreased by Neoadjuvant Treatment (2019) (0)
Loss of miR-204 expression is a key event in melanoma (2018) (0)
IMMUNOlogical microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT) 5: preliminary results on gender difference in immune microenvironment of rectal cancer (2022) (0)
P2.02-065 RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors (2017) (0)
Tu1225 - Postoperative Fever of Unknown Origin is Associated to Lymphopenia after Esophagectomy for Cancer (2018) (0)
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (2022) (0)
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer (2021) (0)
IMMUNOlogical microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT 1; NCT04915326): preliminary results on prediction of presence of nodal metastasis in early rectal cancer (2022) (0)
Abstract 1823: Identification of molecular determinants of vinorelbine resistance in BRAF(V600E) mutated chemorefractory metastatic colorectal cancer patients (2018) (0)
Evolution of HER2-low expression from primary to recurrent breast cancer (2021) (0)
Abstract P2-12-04: Characterization of gut microbiome composition in triple negative breast cancer patients treated with neoadjuvant chemotherapy (2022) (0)
Abstract A085: miR-222/221 in aggressive breast cancer (2013) (0)
On the mechanism of tumor cell entry of aloe‐emodin, a natural compound endowed with anticancer activity (2021) (0)
P.20.6 THE UNIQUE PROFILE OF ANTERIOR GRADIENT 2 (AGR2) IN BARRETT'S METAPLASIA(S) (2012) (0)
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients (2023) (0)
Tu1867 The Capability of Antigen Presentation of Colonic Epithelial Cells Is Essential to Activate an Effective CD8 Response During the Early Phases of the Carcinogenic Progression (2016) (0)
Role of microRNA-182 in skeletal diseases: new therapeutic approaches to prevent bone loss (2019) (0)
Fusion 3D gross sampling method to overcome heterogeneity in clear cell renal cell carcinoma (ccRCC) and grading angiogenic versus immune signatures. (2021) (0)
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes (2016) (0)
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy. (2019) (0)
SO-3 Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma (2022) (0)
Coronary Artery Disease and Gallbladder Inflammatory Pseudopolyps (2022) (0)
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis (vol 63, pg 692, 2010) (2011) (0)
Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia. (2022) (0)
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes (2015) (0)
HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective (2023) (0)
An integrated multi-omics analysis of rectal cancer patients identified POU2F3 as a putative druggable target and entinostat as a cytotoxic enhancer of 5-Fluorouracil. (2023) (0)
Abstract 976: Junctional adhesion molecule-A (JAM-A) expression is downmodulated by miR-21 during colorectal cancer progression (2014) (0)
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (2018) (0)
Non-coding RNA dysregulation in Barrett's carcinogenesis (2014) (0)
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes (2018) (0)
Tumor immune microenvironment in therapy‐naive esophageal adenocarcinoma could predict the nodal status (2022) (0)
OC.02.2: Does “Invisible” Dysplasia in Barrett’S Esophagus Really Exist? (2017) (0)
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells (2012) (0)
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers. (2019) (0)
P0282 : The long non coding RNA UC.158 modulates growth of Wnt/β;-catenin driven hepatocellular carcinoma (HCC) (2015) (0)
Sa1338 NATURAL HISTORY OF AUTOIMMUNE GASTRITIS: PROSPECTIVE LONG-TERM FOLLOW-UP CLINICO-PATHOLOGICAL STUDY (2020) (0)
OC.14.1 IS THE ADHERENCE TO WCRF/AICR RECOMMENDATIONS INVOLVED IN BARRETT'S ESOPHAGUS ONSET AND ITS PROGRESSION TO EAC? A RETROSPECTIVE ANALYSIS IN A HIGH-RISK POPULATION (2018) (0)
P.01.20 FREE RADICALS AND OXIDATIVE STRESS-RELATED GENOMIC DAMAGE:WHICH ROLE IN AUTOIMMUNE GASTRITIS? (2018) (0)
OC.04.6 CIRCULATING PROSTAGLANDIN E2: A NOVEL POTENTIAL PROGNOSTIC BIOMARKER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2021) (0)
OC.08.4 HER2 OVEREXPRESSION IS AN EARLY EVENT IN THE MULTISTEP GASTRIC AND ESOPHAGEAL CARCINOGENESIS MODELS (2012) (0)
Positron emission tomography ( PET ) as a predictive measure in patients with metastatic pancreatic cancer and normal CA 19-9 levels at baseline Two recent MPACT subanalyses (2016) (0)
PO-338 Recurrent glioblastoma: a complex scenario dominated by loss of MMR proteins (2018) (0)
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes (2022) (0)
Validation of the Padova Prognostic Score for Colitis in Predicting Long-Term Outcome After Restorative Proctocolectomy (2021) (0)
483 The Concept of Perihilar Cholangiocarcinoma Is Still Valid? Analysis of Clinicopathological Features and Mutational Genes Profiling in a Series of 56 Cases (2015) (0)
Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches (2023) (0)
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment (2023) (0)
385 MIR-24-3P REGULATES CDX2 DURING THE PROCESS OF INTESTINALIZATION OF THE CARDIAC-TYPE EPITHELIUM IN A HUMAN MODEL OF BARRETT’S ESOPHAGUS (2021) (0)
MALT lymphoma Tumor-associated macrophages as major source of APRIL in gastric (2011) (0)
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241] (2022) (0)
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials (2018) (0)
MicroRNA Expression Profiling of Human Esophageal Metaplastic Changes (2011) (0)
Liver Cancer Classification (2015) (0)
SerpinB3/4 expression is associated with poor prognosis in patients with cholangiocarcinoma (2022) (0)
Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer (2023) (0)
Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
A practical approach for PD-L1 evaluation in gastroesophageal cancer. (2022) (0)
Abstract 156: MicroRNA expression profiling of human esophageal metaplastic changes (2011) (0)
Circulating cell free DNA (cfDNA) as a novel tool to monitor Barrett’s esophagus neoplastic progression (2016) (0)
T06.01.14 A SUDDEN PROPTOSIS: A CASE OF HEPATOCELLULAR CARCINOMA METASTATIC TO THE ORBIT (2020) (0)
Abstract 206: The Consensus Molecular Classification (CMS) of primary colorectal tumors and their matched liver metastasis: Investigating the concordance (2018) (0)
Contents Vol. 100, 2014 (2015) (0)
Leucine zipper putative tumor suppressor 1 - [Isoform 1] (2008) (0)
FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice. (2023) (0)
A real-world application of liquid biopsy (LB) in metastatic colorectal cancer (mCRC). (2020) (0)
PROEPITHELIN IS A NOVEL BIOMARKER FOR PROSTATE CANCER AND REGULATES CELL GROWTH, MIGRATION AND ANCHORAGE-INDEPENDENT GROWTH OF PROSTATE CANCER CELLS (2009) (0)
Special Issue: Next-Generation Sequencing in Tumor Diagnosis and Treatment II (2022) (0)
P.01.5 AUTOFLUORESCENCE IMAGING VIDEOENDOSCOPY (AFI) AND OLGA GASTRITIS STAGING: PROGNOSTIC AND DIAGNOSTIC IMPACT IN A SINGLE ITALIAN CENTRE (2012) (0)
The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer (2022) (0)
The immune microenvironment in pancreatic ductal adenocarcinoma: a potential preoperative marker of lymphnodal involvement (2022) (0)
Loss of Primary Cilia Potentiates BRAF/MAPK Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (CROCC) Alterations (2023) (0)
T01.01.1 ROLE OF MIRNAS IN GASTRIC ATROPHY, AUTOIMMUNITY AND DISEASE PROGRESSION (2020) (0)
78O Immune microenvironment of small cell lung cancer (SCLC): Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumor infiltrating lymphocytes (2018) (0)
116PClinical and pre-clinical biomarkers of Regorafenib (REG) efficacy in metastatic colorectal cancer (mCRC) in a phase II trial (2017) (0)
The GIPAD handbook of the gastrointestinal pathologist (in the Covid-19 era) (2020) (0)
Correlation between p53 expression and clinical outcome in RAS/BRAF wild type metastatic colorectal cancer patients receiving later-line irinotecan-cetuximab (2019) (0)
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors (2022) (0)
T01.01.10 INTEROBSERVER CONSISTENCY ON THE HISTOLOGICAL ASSESSMENT OF SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA (2020) (0)
A Case of Carcinosarcoma of the Gastroesophageal Junction With Neuroendocrine and Chondroid Differentiation (2020) (0)
’ s response to reviews Title : Association between HER 2 status in gastric cancer and clinicopathological features : a retrospective study using whole-tissue sections (2015) (0)
A single institution experience and review of the literature on the rare association between pancreatic neuroendocrine neoplasms and gastrointestinal stromal tumours (2020) (0)
Colorectal adenosquamous carcinoma: genomic profiling of a rare histotype of colorectal cancer (2023) (0)
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre (2022) (0)
Immunohistochemical expression of ectodermin (2006) (0)
OC.07.3 AUTOIMMUNE ATROPHIC GASTRITIS: DIFFERENCES BETWEEN HELICOBACTER PYLORI ASSOCIATED AND NON-ASSOCIATED DISEASE (2022) (0)
259 Micronuclei in hepatocellular carcinoma and its phenotypical precursors (2006) (0)
Histopathologic response and growth patterns of colorectal cancer liver metastases (CRCLM) in patients treated with triplets plus bevacizumab (bev) or anti-EGFRs. (2017) (0)
HSP-90 Inhibition is a Promising Therapeutic Strategy in Cholangiocarcinoma and MIR-21 may Serve as a Biomarker of Sensitivity (2016) (0)
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study (2022) (0)
Patient-derived ECM-scaffolds of colorectal cancer and liver metastases as organotypic 3D model of liver metastatic colonization (2020) (0)
26P Evaluation of tumor-infiltrating lymphocytes on matched baseline and residual disease samples of triple-negative breast cancer patients treated with anthracycline-taxane based neoadjuvant chemotherapy with or without carboplatin (2022) (0)
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4 (2018) (0)
OC.06.3 DUODENUM FINDINGS IN GASTRIC DISEASES: A RETROSPECTIVE HISTOLOGICAL EVALUATION (2019) (0)
Detection of microRNAs as biomarker for anti-EGFR antibody resistance in colon cancer patients (2019) (0)
Su1175 Bone Morphogentic Protein 4 Signaling Alters MicroRNA-145 Expression in the Esophagus (2012) (0)
Abstract 1069: MiR-21 may serve as a predictive biomarker of response in the assessment of efficacy of HSP-90 inhibition in gastrointestinal (GI) cancers (2016) (0)
Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells (2019) (0)
Subject Index Vol. 26, 2009 (2009) (0)
OC.15.6: Autoimmune Gastritis with Previous or Concurrent H. Pylori Infection Presents Distinct Functional and Morphological Features (2017) (0)
Retraction Statement. Paper by Iebba V, Aloi M, Civitelli F, Cucchiara S: Digestive Diseases 2011;29:531-539 (DOI: 10.1159/000332969) (2014) (0)
Abstract A045: Multiple roles for plasticity in metastasis and therapy resistance in long-term survivors of metastatic colorectal cancer (2022) (0)
Screening for genes down-regulated in esophageal cancers ( (0)
PD-L 1 and CD 163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells : expression patterns and clinical implications (2018) (0)
Tumor mutation burden: from comprehensive mutational screening to the clinic (2019) (0)
A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer (2018) (0)
AB021. S021. Expression patterns and clinical implications of immunotherapy targets PD-1, PD-L1 and CD163 in undifferentiated carcinoma of the pancreas with osteoclastlike giant cells (2018) (0)
Long-Standing Ulcerative Colitis May Trigger a Multilineage Cancerization Field (2018) (0)
OC.07.6 SERUM BIOMARKERS CAN IDENTIFY PATIENTS WITH AUTOIMMUNE AND H. PYLORI-RELATED ATROPHIC GASTRITIS AND DIFFERENTIATE THOSE WITH ADVANCED GASTRIC CHANGES (2016) (0)
OLGA Gastritis Staging & Intestinal Metaplasia Histochemistry (2011) (0)
The diagnostic value of miR17-92 microRNA cluster in diffuse large B-cell lymphoma (2013) (0)
P02.02.A Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: a large mono institutional experience (2022) (0)
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? (2022) (0)
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis (2017) (0)
Erratum: The microbiota in inflammatory bowel disease in different age groups (Digestive Diseases (2009) 27 (252-258) DOI: 10.1159/000228558) (2014) (0)
268 LIQUID BIOPSY IN ESOPHAGEAL ADENOCARCINOMA: ROLE OF LINE-1 HYPOMETHYLATION (2020) (0)
Assessment of minimum biopsy set for HER2 status evaluation in gastric and gastro-esophageal adenocarcinoma (2013) (0)
Molecular Biology of Neuroendocrine Tumors (2021) (0)
OC.10.3 LONG-TERM PROGNOSTIC IMPACT OF ISOLATED TUMOUR CELLS IN PN0 COLORECTAL CANCER: A PROSPECTIVE MONOINSTITUTIONAL STUDY (2010) (0)
Is there a correlation between clinic-pathological features, MSI, PD-L1 and survival outcomes in resected gastric cancer? Looking for optimal biomarkers. (2019) (0)
Contents Vol. 26, 2009 (2009) (0)
Abstract 530: MicroRNA expression profiling in MMTV-neubreast cancer mouse model (2014) (0)
Tryptophan metabolism along the kynurenine and serotonin pathways reveals substantial differences in colon and rectal cancer (2017) (0)
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer (2019) (0)
PC.01.9 ESOPHAGEAL MICROBIOTA COMPOSITION ACROSS BARRETT'S ESOPHAGUS-DYSPLASIA-EAC SEQUENCE (2019) (0)
High miR-224 expression in cholangiocarcinoma may predict survival (2018) (0)
Histopathological Landscape of Precursor Lesions of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (2022) (0)
AUTHOR'S RESPONSE (2009) (0)
Tu1294 – Esophageal Adenocarcinoma Microenvironment: Leptin Expression in Peritumoral Adipose Tissue is Associated with Tumor Grading and Staging, Higher Immune Infiltration Within the Tumor and Neoadjuvant Treatment (2019) (0)
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair–deficient metastatic colorectal cancer: Immunological and molecular profiling (2022) (0)
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma (2018) (0)
Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability (2022) (0)
Tu1270 High Levels of CD4+ T Cell Is Associated to Recurrence/Relapse After Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus (2016) (0)
Abstract 3219: Isolated tumor cells (ITC) in regional lymph nodes predict colorectal cancer (CRC) relapse (2011) (0)
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? (2021) (0)
OC.06.1 THE IMMUNITY-INFLAMMATION-CANCER PATHWAY IN AUTOIMMUNE GASTRITIS: ROLE OF THE OXIDATIVE STRESS (2019) (0)
P.10.28 INSULIN RESISTANCE IN BARRETT'S ESOPHAGUS DEVELOPMENT AND EVOLUTION TO CANCER (2014) (0)
ctDNA as promising tool for the assessment of minimal residual disease (MRD) and the need of an adjuvant treatment in gastroesophageal adenocarcinoma (2022) (0)
Correction to: Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability (2022) (0)
Squamous cell carcinoma antigen in human liver carcinogenesis. (IF 2.426) (2008) (0)
YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS–STING (2022) (0)
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (2019) (0)
P1.15-06 Immune-Checkpoint Inhibitors-Related Colitis in Advanced Non-small Cell Lung Cancer Patients: A Real-World Analysis (2022) (0)
Prognostic value of the immune-related transcriptome in biliary tract cancers (2016) (0)
Abstract PD7-08: Gene Expression Profiling of Breast Cancer Brain Metastasis shows enrichment for non-luminal subtypes with potential prognostic implications (2023) (0)
Micronuclei in hepatocellular carcinoma and its phenotypical precursors (2006) (0)
HER2 expression and extensive molecular characterization of resected brain metastases from colorectal cancer: The HEROES study. (2022) (0)
OC.07.7 INSULIN-MEDIATED ESOPHAGEAL ADENOCARCINOMA DEVELOPMENT RELATED TO CHRONIC DUODENUM-ESOPHAGEAL REFLUX IN A HYPERINSULINEMIC AND NON-OBESE MURINE MODEL (2016) (0)
IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study. (2023) (0)
OC.03.1 LOW ADHERENCE TO WORLD CANCER RESEARCH FUND (WCRF) LIFESTYLE RECOMMENDATIONS AFFECTS THE METABOLISM AND ESOPHAGEAL MICROBIOTA COMPOSITION IN PATIENTS WITH BARRETT'S ESOPHAGUS (2020) (0)
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
KRAS induces lung tumorigenesis through microRNAs modulation (2018) (0)
A better lens on disease: a better pathologist beyond the lens. (2010) (0)
PC.01.8 SERUM DETERMINATION OF SQUAMOUS CELLULAR CARCINOMA ANTIGEN AS A BIOMARKER OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER: A PHASE III STUDY (2016) (0)
Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors. (2023) (0)
Molecular Determinants of Peritoneal Dissemination in Gastric Adenocarcinoma (2022) (0)
Isolated Tumor Cells (ITC) in Regional Lymph Nodes Predict Colorectal Cancer (CRC) Relapse (2011) (0)
Dasatinib-induced Crohn’s-like colitis (2022) (0)
Preoperative endoscopy and pathology report of the specimen to be recommended in sleeve gastrectomy? (2023) (0)
640PMOLECULAR PORTRAIT OF RESECTED GASTRIC CANCER (RGC) WITH NEXT GENERATION SEQUENCING (NGS) ACCORDING TO A CLINICAL BIOLOGICAL RISK MODEL CONSIDERING FHIT, APC AND HER-2 OVEREXPRESSION. (2014) (0)
P1.07-020 Surgical Resected Small Cell Lung Cancers (SCLCs): A Monocentric Retrospective Analysis: Topic: Local Treatment (2017) (0)
Non‐small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series: 166P (2016) (0)
Pancreatic Neuroendocrine Neoplasms Larger than 4 cm: A Retrospective Observational Study of Surgery, Histology, and Outcome (2023) (0)
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of response to DNA damage (2019) (0)
Gastrointestinal pathology in infantile and pediatric patients: the evidence of a pattern-based histological approach and of a multidisciplinary integration (2022) (0)
Contrast-Enhanced CT Texture Analysis in Colon Cancer: Correlation with Genetic Markers (2022) (0)
948: Genetic variants of susceptibility in second primary esophageal cancer patients (2014) (0)
Abstract CT261: METAMECH -A Master Observational Trial empowering mechanobiology translational research and mechanobased proof of concept trials in breast cancer (2020) (0)
TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions (2022) (0)
Prognostic role of BAP1 and PBRM1 expression in intrahepatic cholangiocarcinoma (2018) (0)
Sa665 STRICTUREPLASTY FOR CROHN'S DISEASE: INTESTINAL INFLAMMATION IS HIGH BUT PROGRESSIVELY DECREASES IN THE LONG TERM POSTOPERATIVE FOLLOW UP (2021) (0)
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy. (2023) (0)
T01.02.2 ENDOSCOPIC AND PATHOLOGIC SECOND OPINION FOR BARRETT'S ESOPHAGUS (BE) ASSOCIATED DYSPLASIA: THE EXPERIENCE OF A NORTHEAST REFERENCE CENTER (2020) (0)
a detailed clinical, pathological and molecular characterization (2019) (0)
Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (0)
Immunotherapy in RAS mutant mCRC: Could CTLA-4 blockade increase the efficacy of anti PD-1 agents? Preliminary clinical results of the NERDY study. (2023) (0)
Retraction Statement. Paper by Krznarić Ž, Vranešić Bender D, Kunović A, Kekez D, Štimac D: Digestive Diseases 2012;30:196-200 (DOI: 10.1159/000336965) (2014) (0)
Monitoring advanced non-small cell lung cancer (NSCLC) through plasma genotyping during systemic treatment: KRAS-mutated (m) cohort results. (2018) (0)
T01.01.8 NATURAL HISTORY OF AUTOIMMUNE GASTRITIS: PROSPECTIVE LONG-TERM FOLLOW-UP CLINICO-PATHOLOGICAL STUDY (2020) (0)
P01.018 Mismatch repair deficiency (MMRd) in glioma patients (PTS): frequency and correlation with clinical, histological and molecular characteristics (2018) (0)
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study (2023) (0)
Abstract LB-245: Multiple DNA-damage response pathways are modulated by RANBP9 protein in NSCLC (2018) (0)
A case of lethal varicose vein rupture caused by massive leiomyoma. (2021) (0)
1023: IMMUNOREACT 6: YOUNG PATIENTS WITH RECTAL CANCER HAVE A LOWER INFILTRATION OF CD4+ T CELLS WITHIN THE HEALTY RECTAL MUCOSA BUT NO MISMATCH REPAIR GENES DEFECTS. (2022) (0)
647PATM loss, MSI and survival in the MAGIC trial (2017) (0)
Abstract A60: The hMENA Splicing Program: An important regulator of TGFβ1-driven EMT and invasiveness in pancreatic cancer (2015) (0)
Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel (2023) (0)
Feasibility of multiple immunoexpression assay for immune tumor micrornvironment (I-TME) on matched metastatic and primary renal cell carcinoma (RCC) for patient prognostication and predictiveness to immunotherapy (preliminary analyses of the Meet URO 18 study). (2021) (0)
Abstract A112: RanBP9 protects cells from genotoxic stress and increased expression is predictive of worse response to platinum in NSCLC patients (2018) (0)
OC.15.3: Prevalence and Pathophysiology of Gastro-Esophageal Reflux Disease in Patients with Autoimmune Gastritis (2017) (0)
for identifying the (2016) (0)
Correlation between clinic-pathological features, MSI, PD-L1 and survival in resectable gastric cancer: Looking for prognostic biomarkers. (2018) (0)
Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (2018) (0)
ProfilingUsing MicroRNA Expression Carcinoma in Transthoracic Needle Classification of Non-small Cell Lung (2011) (0)
Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
Abstract 5720: MicroRNA deregulation of the serine synthesis pathway controls intrinsic and non-cell autonomous mechanism of resistance to Regorafenib in metastatic colorectal cancer (mCRC) (2020) (0)
A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study (2022) (0)
Metachronous colorectal cancer have a similar microsatellite instability frequency but a lower infiltration of lymphomononuclear cells than primary lesions. (2022) (0)
Molecular Typing of Lung Adenocarcinoma on Cytological Samples in the Next-Generation Sequencing Era (2015) (0)
Relationship between tumor infiltrating lymphocytes and clinicopathological features in Peruvian gastric cancer. (2022) (0)
Abstract 1135: DRD2 is critical for pancreatic cancer and promises pharmacological therapy by already established antagonists (2017) (0)
MAP Kinase inhibition reshapes tumor microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages (2019) (0)
Magnetic resonance Imaging (MRI), liquid biopsies, and patient derived organoids (PDOs) as biomarkers of response to regorafenib (REG) in treatment-refractory metastatic colorectal cancer (mCRC) patients (pts). (2017) (0)
P.08.4: Prevention of Esophageal Adenocarcinoma in Barrett’s Esophagus Patients: A Moderate Calorie-Protein Restriction Program (CARE-PRO) (2017) (0)
1040: ROLE OF TUMORAL AND PERITUMORAL IMMUNE MICROENVIRONMENT IN PANCREATIC DUCTAL ADENOCARCINOMA: A POTENTIAL PREDICTOR OF PROGNOSIS (2022) (0)
Comparative Lesions Analysis Through a Targeted Sequencing Approach. (2019) (0)
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis (2019) (0)
778: IMMUNOREACT 5: FEMALE PATIENTS WITH RECTAL CANCER HAVE A HIGHER EXPRESSION OF PDL-1 AND A HIGHER INFILTRATION OF T-CELLS WITHIN THE RECTAL MUCOSA. (2022) (0)
Nrf2 and Her3 co-expression in cholangiocarcinoma: Possible biological pathways for potential therapeutic approach. (2023) (0)
Abstract 1269: Negative ultra-selection of patients with RAS/BRAF wild-type (wt), microsatellite stable (MSS) metastatic colorectal cancer (mCRC) receiving anti-EGFR-based therapy: The PRESSING2 study (2022) (0)
Su1114 Autofluorescence Imaging Videoendoscopy (AFI) and OLGA Gastritis Staging: Prognostic and Diagnostic Impact in a Single Italian Centre (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Matteo Fassan?

Matteo Fassan is affiliated with the following schools:

University of Milan
Ohio State University
University of Verona
Semmelweis University
University of Padua